Object. Cerebrospinal fluid (CSF) shunts effectively reverse symptoms of pseudotumor cerebri postoperatively, but long-term outcome has not been investigated. Lumboperitoneal (LP) shunts are the mainstay of CSF shunts for pseudotumor cerebri; however, image-guided stereotaxy and neuroendoscopy now allow effective placement of a ventricular catheter without causing ventriculomegaly in these cases. To date it remains unknown if CSF shunts provide long-term relief from pseudotumor cerebri and whether a ventricular shunt is better than an LP shunt. The authors investigated these possibilities.
Methods. The authors reviewed the records of all shunt placement procedures that were performed for intractable headache due to pseudotumor cerebri at one institution between 1973 and 2003. Using proportional hazards regression analysis, predictors of treatment failure (continued headache despite a properly functioning shunt) were assessed, and shunt revision and complication rates were compared between LP and ventricular (ventriculoperitoneal [VP] or ventriculoatrial [VAT]) shunts.
Forty-two patients underwent 115 shunt placement procedures: 79 in which an LP shunt was used and 36 in which a VP or VAT shunt was used. Forty patients (95%) experienced a significant improvement in their headaches immediately after the shunt was inserted. Severe headache recurred despite a properly functioning shunt in eight (19%) and 20 (48%) patients by 12 and 36 months, respectively, after the initial shunt placement surgery. Seventeen patients without papilledema and 19 patients in whom preoperative symptoms had occurred for longer than 2 years experienced recurrent headache, making patients with papilledema or long-term symptoms fivefold (relative risk [RR] 5.2, 95% confidence interval [CI] 1.5–17.8; p < 0.01) or 2.5-fold (RR 2.51, 95% CI 1.01–9.39; p = 0.05) more likely to experience headache recurrence, respectively. In contrast to VP or VAT shunts, LP shunts were associated with a 2.5-fold increased risk of shunt revision (RR 2.5, 95% CI 1.5–4.3; p < 0.001) due to a threefold increased risk of shunt obstruction (RR 3, 95% CI 1.5–5.7; p < 0.005), but there were similar risks between the two types of shunts for overdrainage (RR 2.3, 95% CI 0.8–7.9; p = 0.22), distal catheter migration (RR 2.1, 95% CI 0.3–19.3; p = 0.55), and shunt infection (RR 1.3, 95% CI 0.3–13.2; p = 0.75).
Conclusions. Based on their 30-year experience in the treatment of these patients, the authors found that CSF shunts were extremely effective in the acute treatment of pseudotumor cerebri—associated intractable headache, providing long-term relief in the majority of patients. Lack of papilledema and long-standing symptoms were risk factors for treatment failure. The use of ventricular shunts for pseudotumor cerebri was associated with a lower risk of shunt obstruction and revision than the use of LP shunts. Using ventricular shunts in patients with papilledema or symptoms lasting less than 2 years should be considered for those with pseudotumor cerebri—associated intractable headache.
Address reprint requests to: Daniele Rigamonti, M.D., The Johns Hopkins Adult Hydrocephalus Program, Department of Neurosurgery, The Johns Hopkins School of Medicine, 600 North Wolfe Street, Phipps 104, Baltimore, Maryland 21287. email: email@example.com.
AmacherALSpenceJD: Spectrum of benign intracranial hypertension in children and adolescents.Childs Nerv Syst1:81–861985Amacher AL Spence JD: Spectrum of benign intracranial hypertension in children and adolescents. Childs Nerv Syst 1:81–86 1985
BeattyRA: Cervical-peritoneal shunt in the treatment of pseudotumor cerebri. Technical note.J Neurosurg57:853–8551982Beatty RA: Cervical-peritoneal shunt in the treatment of pseudotumor cerebri. Technical note. J Neurosurg 57: 853–855 1982
BulensCDe VriesWAVan CrevelH: Benign intracranial hypertension. A retrospective and follow-up study.J Neurol Sci40:147–1571979Bulens C De Vries WA Van Crevel H: Benign intracranial hypertension. A retrospective and follow-up study. J Neurol Sci 40:147–157 1979
BurgettRAPurvinVAKawasakiA: Lumboperitoneal shunting for pseudotumor cerebri.Neurology49:734–7391997Burgett RA Purvin VA Kawasaki A: Lumboperitoneal shunting for pseudotumor cerebri. Neurology 49:734–739 1997
CalabreseVPSelhorstJBHarbisonJW: CSF infusion test in pseudotumor cerebri.Trans Am Neurol Assoc103:146–1501978Calabrese VP Selhorst JB Harbison JW: CSF infusion test in pseudotumor cerebri. Trans Am Neurol Assoc 103:146–150 1978
EggenbergerERMillerNRVitaleS: Lumboperitoneal shunt for the treatment of pseudotumor cerebri.Neurology46:1524–15301996Eggenberger ER Miller NR Vitale S: Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 46:1524–1530 1996
GjerrisFSoelberg-SorensenPVorstrupSet al: Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri).Ann Neurol17:158–1621985Gjerris F Soelberg-Sorensen P Vorstrup S et al: Intracranial pressure conductance to cerebrospinal fluid outflow and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol 17:158–162 1985
GuessHACharltonJDJohnsonRNet al: A nonlinear least-squares method for determining cerebrospinal fluid formation and absorption kinetics in pseudotumor cerebri.Comput Biomed Res18:184–1921985Guess HA Charlton JD Johnson RN et al: A nonlinear least-squares method for determining cerebrospinal fluid formation and absorption kinetics in pseudotumor cerebri. Comput Biomed Res 18:184–192 1985
JannyPChazalJColnetGet al: Benign intracranial hypertension and disorders of CSF absorption.Surg Neurol15:168–1741981Janny P Chazal J Colnet G et al: Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 15:168–174 1981
JohnstonIBesserMMorganMK: Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension.J Neurosurg69:195–2021988Johnston I Besser M Morgan MK: Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 69:195–202 1988
JohnstonIPatersonA: Benign intracranial hypertension. I. Diagnosis and prognosis.Brain97:289–3001974Johnston I Paterson A: Benign intracranial hypertension. I. Diagnosis and prognosis. Brain 97:289–300 1974
JohnstonIPatersonA: Benign intracranial hypertension. II. CSF pressure and circulation.Brain97:301–3121974Johnston I Paterson A: Benign intracranial hypertension. II. CSF pressure and circulation. Brain 97:301–312 1974
KangS: Efficacy of lumbo-peritoneal versus ventriculo-peritoneal shunting for management of chronic hydrocephalus following aneurysmal subarachnoid haemorrhage.Acta Neurochir142:45–492000Kang S: Efficacy of lumbo-peritoneal versus ventriculo-peritoneal shunting for management of chronic hydrocephalus following aneurysmal subarachnoid haemorrhage. Acta Neurochir 142:45–49 2000
RosenbergMLCorbettJJSmithCet al: Cerebrospinal fluid diversion procedures in pseudotumor cerebri.Neurology43:1071–10721993Rosenberg ML Corbett JJ Smith C et al: Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 43:1071–1072 1993
SklarFHBeyerCWJrRamanathanMet al: Cerebrospinal fluid dynamics in patients with pseudotumor cerebri.Neurosurgery5:208–2161979Sklar FH Beyer CW Jr Ramanathan M et al: Cerebrospinal fluid dynamics in patients with pseudotumor cerebri. Neurosurgery 5:208–216 1979
TherneauTM: Extending the Cox model in LinDYFlemingTR (eds): Proceedings of the First Seattle Symposium in Biostatistics: Survival Analysis.New York: Springer-Verlag1997 pp 51–84Therneau TM: Extending the Cox model in Lin DY Fleming TR (eds): Proceedings of the First Seattle Symposium in Biostatistics: Survival Analysis. New York: Springer-Verlag 1997 pp 51–84